This compound is a pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients (APIs). It features a piperazine ring and a chlorophenyl-substituted cyclohexene core, giving it moderate lipophilicity and a single hydrogen-bond donor.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1228780-72-0
1-((4'-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine dihydrochloride
pharmaceutical intermediate
O-Benzylglycine toluene-p-sulphonate
pharmaceutical intermediate for API synthesis
4-(4-Chlorobutyl)pyridine hydrochloride
pharmaceutical intermediate for API synthesis
4-(Benzyloxycarbonyl)phenylboronic acid
pharmaceutical intermediate for API synthesis
Benzyl (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo-(2,3-e)pyrazin-8-yl)pyrrolidine-1-carboxylate
pharmaceutical intermediate for API synthesis
Ru(Me-allyl)2(COD)
Pharmaceutical intermediate for ruthenium complexes
6-bromopyridine-2-carbonitrile
pharmaceutical intermediate
(R)-methyl 4-((3R,5S,10S,13R,17R)-10,13-dimethyl-7-oxo-3-(tetrahydro-2H-pyran-2-yloxy)-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
Pharmaceutical intermediate for steroid synthesis
1-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazine
YCNNHDUZLQPKJY-UHFFFAOYSA-N
CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCNCC3)C
—